ACIDE GADOTERIQUE GUERBET 0.5 mmol/ml, solution for injection in a pre-filled syringe syringe, 15 ml, CIP 3400930222508
Active ingredients: Gadoteric acid, DOTA, Gadolinium(III) oxide
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injectionsyringe, 15 ml, CIP 3400930222508intraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ACIDE GADOTERIQUE GUERBET 0,5 mmol/mL, solution injectable en seringue pré-remplie
- Pharmaceutical form
- solution injectable
- Route of administration
- intraveineuse
- Presentation description
- 1 seringue(s) préremplie(s) plastique polypropylène de 15 ml avec dispositif(s) d'administration pour injecteur(s) Optistar Elite (seringue 60 mL + raccord + cathéter sécurisé 20G)
- Marketing authorisation holder
- GUERBET
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 23 May 2023
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64913426CIP73022250CIP133400930222508Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| OXYDE DE GADOLINIUMsolution | — | SA |
| ACIDE GADOTÉRIQUEsolution | 279,32 mg · 1 mL de solution | FT |
| DOTAsolution | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.